Please assess the completion status of the following clinical trial:

Trial Title: Contrast Enhanced Ultrasonography (CEUS) of Patients With Crohn's Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Deterioration of Crohn's disease~* CDAI\>150~* Treated with systemic steroids or TNF alfa inhibitors~* Lesion found on ultrasound~Exclusion Criteria:~* Disease location not reachable with ileocolonoscopy~* Pregnancy~* Acute coronary disease~* Unstable coronary disease~* Previous allergic reaction to SonoVue or its components

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Deterioration, Crohn's disease (Type: None): Patients \> 18 years old with a deterioration of Crohn's disease defined by CDAI \>150 and requiring treatment with systemic steroids or TNF alfa inhibitors

Based on this trial design, predict the completion outcome and termination type (if applicable).